Cataract device safety tracked over 20 months in extension study
NCT ID NCT07246915
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 61 people who previously used the REVISYON SDS 100 device for mild-to-moderate cataract. Researchers will check for side effects and measure vision changes over about 20 months. No new treatment is given; the goal is to see if the device stays safe and works well long-term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
REVISYON SDS 100 medical device
What this could lead to
If successful, this study could confirm that the device remains safe and effective over the long term for treating mild-to-moderate cataract.
What could go wrong
This is an observational extension study with no new treatment, so it cannot prove the device works better than other options. Results depend on data from a prior study and may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Berghian Ophthalmology Clinic
Timișoara, Romania
-
Institutul Clinic de Urgențe Oftalmologice Prof. Dr. Mircea Olteanu
Bucharest, Romania
-
Opticlass Clinic
Timișoara, Romania
-
Romania Clinica Vista, Ophtalmology Department
Timișoara, Romania
-
Spitalul Clinic CF Timisoara, Ophthalmology Department
Timișoara, Romania
-
Vedis Ophthalmology Clinic | Ophthalmological Center Dr. Samoila
Cluj-Napoca, Romania